Compositions and methods for drug sensitization of parasites
AssigneeThe Texas A&M University System
InventorsJames C. Sacchettini, Matthew W. Miller, Deeann Wallis, Nian E. Zhou, Theresa W. Fossum
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Texas A&M University System
InventorsJames C. Sacchettini, Matthew W. Miller, Deeann Wallis, Nian E. Zhou, Theresa W. Fossum
Estimating the term…
Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a rifamycin derivative or a pharmaceutically acceptable salt, hydrate, or prodrug thereof in an amount and formulation sufficient to inhibit or induce drug-sensitization in a parasite. The methods can comprise administering a rifamycin derivative or a pharmaceutically acceptable salt, hydrate, or prodrug thereof to a parasite in an amount and formulation sufficient to inhibit or induce drug-sensitization in the parasite.
A composition comprising a rifamycin derivative or a pharmaceutically acceptable salt, hydrate, or prodrug thereof in an amount and formulation sufficient to induce drug-sensitization in a parasite.
(canceled)
(canceled)
A method of sensitizing a parasite to a drug comprising administering rifamycin or a rifamycin derivative to the parasite in an amount and for a time sufficient to sensitize the parasite to the drug.
(canceled)
A method of preventing symptomatic infection of an organism by a parasite or treating infection of an organism by a parasite with a drug comprising:
25-41. (canceled)
Dependencies are inferred from the claim text.